Blair Williams Todt - Dec 14, 2023 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role
EVP, CLO & CAO
Signature
/s/ Kathleen S. Kiefer, Attorney in fact
Stock symbol
ELV
Transactions as of
Dec 14, 2023
Transactions value $
-$947,590
Form type
4
Date filed
12/15/2023, 04:28 PM
Previous filing
Dec 5, 2023
Next filing
Jan 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELV Common Stock Options Exercise $1.71M +5.49K +43.89% $311.48 18K Dec 14, 2023 Direct
transaction ELV Common Stock Sale -$2.66M -5.49K -30.5% $484.02 12.5K Dec 14, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELV Employee Stock Option (Right to Buy) Options Exercise $0 -5.49K -66.67% $0.00 2.75K Dec 14, 2023 Common Stock 5.49K $311.48 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option represents a right to purchase a total of 8,238 shares, and is exercisable in three annual installments of 2,746 shares each, beginning on 3/1/2022, which is the one-year anniversary of the option grant date.